Valuation Indivior Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 11/06/2026 BST			5-day change	1st Jan Change
38.13 ^USD	+0.11%		+1.82%	+6.27%

06-10	Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing	MT
05-20	Indivior Pharmaceuticals Announces Findings From Real-World Evidence Studies on Monthly Injectable Buprenorphine	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,649	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	3.78%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,703	4,245	3,721
Change	-	55.81%	-17.52%	-21.95%	193.72%	2.16%	-9.74%	-12.36%
P/E Ratio	12.8x	-57.2x	1,527x	-34.5x	21.9x	12x	11.1x	9.78x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0.1x	1.33x	0.7x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.7x	3.61x	3.38x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.74x	3.3x	2.71x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	7.2x	6.15x	5.18x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	7.55x	6.63x	5.32x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	13.1x	8.76x	6.91x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	7.66%	11.4%	14.5%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.175	3.44	3.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,258	1,287	1,374
EBITDA ¹	202	225	288	338	428	652.9	690.5	718.4
EBIT ¹	187	212	269	312	415	623.3	640	698.8
Net income ¹	205	-53	2	-48	210	414.5	454.9	517.4
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	38.13	38.13	38.13
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	121,922	-	-
Announcement Date	16/02/22	16/02/23	22/02/24	20/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	12.01x	3.74x	7.2x	-	4.65B
ELI LILLY AND COMPANY	33.97x	12.34x	25.42x	0.59%	1,035B
JOHNSON & JOHNSON	25.47x	5.87x	15.96x	2.24%	574B
ABBVIE INC.	27.52x	6.71x	13.7x	3.05%	397B
ROCHE HOLDING AG	17.45x	4.31x	10.59x	3.08%	324B
ASTRAZENECA PLC	22.84x	4.75x	13.5x	1.84%	281B
NOVARTIS AG	21.11x	5.44x	13.22x	2.98%	278B
NOVO NORDISK A/S	12.49x	4.69x	9.58x	4.02%	193B
AMGEN INC.	23.02x	6.15x	10.74x	2.85%	191B
GILEAD SCIENCES, INC.	-45.04x	5.44x	30.73x	2.58%	156B
Average	15.08x	5.94x	15.06x	2.58%	343.46B
Weighted average by Cap.	22.85x	7.57x	17.63x	2.09%